Singapore markets closed

TXG Dec 2024 25.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
7.060.00 (0.00%)
As of 11:46AM EDT. Market open.
Full screen
Previous close7.06
Open7.06
Bid7.30
Ask8.60
Strike25.00
Expiry date2024-12-20
Day's range7.06 - 7.06
Contract rangeN/A
Volume20
Open interest33
  • PR Newswire

    New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies

    10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that its Xenium In Situ platform was used in a study published in the Journal of Dental Research, offering novel insights into cellular mechanisms regulating the formation of the secondary palate. The study was led by researchers at the National Institutes of Health (NIH) in collaboration with computational experts at the University of Connecticut's Schools of Medicine and Dental Medicine.

  • Insider Monkey

    Does 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead?

    Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Small Company Fund returned 0.48%, significantly underperforming the Russell 2000 Growth index’s 7.58% return. Following the release of the inflation report in February, the […]

  • PR Newswire

    10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel

    10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping its new Xenium Prime 5K Pan-Tissue and Pathways panel. The new panel features an enhanced chemistry to increase plex by an order of magnitude while delivering excellent per-gene sensitivity, improved specificity and spatial fidelity, integrated multimodal cell segmentation and industry-leading speed and throughput.